Sunday, March 24, 2019
Redactor's Choice
You are here: Home / Categories / Health & Beauty (page 73)

Health & Beauty

GSK and Save the Children launch $1 million award to discover new healthcare innovations for reducing child deaths


GSK and Save the Children today launched a $1 million Healthcare Innovation Award to identify and reward innovations in healthcare which have proven successful in reducing child deaths in developing countries. From the 27th June – 26th August, organisations from across the developing world can nominate examples of innovative healthcare approaches they have discovered or implemented. These approaches must have resulted in tangible improvements to under-5 child survival rates, be sustainable and have the potential to be scaled-up and replicate... Read More »

Pfizer plans to work with the European medicines agency (EMA) to resubmit marketing authorization application (MAA)


While the CHMP considered that treatment with XELJANZ resulted in reduction in the signs and symptoms of RA and improvement in the physical function of patients, it has outstanding concerns on safety, including serious infections. The Company is currently evaluating the feedback from the CHMP and will determine next steps to resubmit a MAA to the EMA. “We are disappointed in the outcome of the re-examination process. A narrow majority of the CHMP felt there is too limited experience in the patient population to fully characterize the prof... Read More »

EU – Finding a cure for a rare and debilitating genetic disease


DevelopAKUre is a European Union (EU)-funded research project which is working to establish a safe, reliable treatment for a rare and hitherto incurable disease. Caused by a genetic mutation, Alkaptonuria (AKU) leads to a severe and early-onset form of osteoarthritis and can also cause heart problems. AKU sufferers have an enzyme deficiency which leaves them unable to break down a naturally occurring substance within the body known as homogentisic acid, or HGA. HGA builds up in body tissues, in particular attacking cartilage and making it br... Read More »

High Rate of early delirium after surgery in older adults


Delirium occurring early after surgery is linked to decreased cognitive (mental) function and an increased rate of nursing home admission, according to the study by Dr. Karin J. Neufeld of Johns Hopkins University and colleagues. They write, "Recognizing delirium in the PACU may be important for identifying patients at higher risk of in-hospital harms…as well as cognitive impairment and institutionalization at hospital discharge." Many Older Patients Have Delirium after Surgery The researchers performed testing for delirium in the PACU (r... Read More »

Shakira named new global ambassador across the worldwide 3D White collection from Oral-B and crest


3D White announces its first ever global partnership with multi-platinum artist and two time GRAMMY award-winning star, Shakira. The brand, known for creating whiter, brighter smiles around the world, identified Shakira as someone who truly celebrates a woman’s everyday multi-dimensional brilliance; reflected through the dazzle of her smile. “We are excited to announce Shakira as the exclusive global spokesperson for our 3D White property, around the world," said Stephen Squire, Global Marketing Director, P&G Oral Care. “As an award-winn... Read More »

Successful launch of care provision program for COPD patients in Germany


High patient acceptance Bosch Healthcare, Techniker Krankenkasse and Robert-Bosch-Krankenhaus aim to enhance patients‘ quality of life High patient and physician engagement The program provides Germany-wide support for 171 critically ill TK patients suffering from Chronic Obstructive Pulmonary Disease (COPD). Patients participating in the program use the Bosch Telehealth system to answer questions about their respiratory condition, vital signs such as oxygen saturation and information about their general state of health on a daily basi... Read More »

Oriflame Cosmetics concludes share buyback programme


According to the buyback programme, the Company was to purchase own shares or SDRs up to a maximum value of SEK 350m during the period from 2 January 2013 to latest 23 April 2013. The programme was implemented in accordance with Commission Regulation No. 2273/2003 of 22 December 2003. Oriflame’s accumulated share buybacks in the period from 2 January 2013 to 12 April 2013 total 1,613,409 shares (corresponding to 2.8% of the total number of outstanding shares of 57,121,134 shares) at the total purchase sum of SEK 349,999,848, to an average pr... Read More »

The company MAQUET took part in the scientific and practical conference with international participation


In order to discuss and find optimal solutions form a single urban system of care for acute coronary syndrome, the conference was attended not only by specialists in St. Petersburg and other cities of the Russian Federation, but also experts from the Czech Republic, the United States, Estonia, Hungary and Lithuania. Conference topics cover topical issues such as: organization and coordination of care for acute coronary syndrome, the practical aspects of patient management, including pre-hospital care, medical treatment, endovascular interven... Read More »

UK: Aviva enhances critical illness cover with conditions that affect customers most


Cover now includes 53 conditions, 17 of which are ABI+ IFA market-leading heart attack definition – severity level lowered significantly Extended scope of three of the five most claimed for conditions: heart attack, stroke and multiple sclerosis Child death benefit added Adviser online video available to explain enhancements This follows specific recommendations from Aviva’s protection claims team to ensure as many cases as possible will be paid. After analysing which types of claims couldn’t be paid due to criteria not being met, th... Read More »

Patients still subject to a ‘postcode lottery’ say MPs


More than two thirds of MPs believe patients in the UK still suffer a ‘postcode lottery’ when trying to access the medicines they need, according to new research out today. A poll by Populus and Pfizer Ltd also revealed that four in five MPs have been approached by constituents or patient groups with concerns about the NHS refusing to fund treatments that have been approved by the National Institute for Health and Care Excellence (NICE). NICE was set up to help eradicate inconsistent access to medicines across the UK. By law, local health... Read More »

Scroll To Top